Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Therapeutics Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Transplants Medicine & Life Sciences
Skin Medicine & Life Sciences
PCI 32765 Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Peripheral T-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2023

Research Output 2013 2017

  • 41 Citations
  • 2 Scopus h-Index
  • 5 Article
  • 2 Review article
  • 1 Short survey
Peripheral T-Cell Lymphoma
Skin
ixazomib
Cell Survival
Cutaneous T-Cell Lymphoma

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

Wang, M., Schuster, S. J., Phillips, T., Lossos, I. S., Goy, A., Rule, S., Hamadani, M., Ghosh, N., Reeder, C. B., Barnett, E., Bravo, M. L. C. & Martin, P. Nov 2 2017 In : Journal of Hematology and Oncology. 10, 1, 171

Research output: Research - peer-reviewArticle

Mantle-Cell Lymphoma
Observational Studies
Therapeutics
PCI 32765
lenalidomide
2 Citations

RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106

Chen, R. W. , Li, H. , Bernstein, S. H. , Kahwash, S. , Rimsza, L. M. , Forman, S. J. , Constine, L. , Shea, T. C. , Cashen, A. F. , Blum, K. A. , Fenske, T. S. , Barr, P. M. , Phillips, T. , Leblanc, M. , Fisher, R. I. , Cheson, B. D. , Smith, S. M. , Faham, M. , Wilkins, J. , Leonard, J. P. & 2 others Kahl, B. S. & Friedberg, J. W. Mar 1 2017 In : British Journal of Haematology. 176, 5, p. 759-769 11 p.

Research output: Research - peer-reviewArticle

Mantle-Cell Lymphoma
Hematopoietic Stem Cells
Transplants
Bendamustine Hydrochloride
Rituximab

Surveillance Scans in Lymphoma: Friend or Foe?

Phillips, T. & Mercer, J. Feb 1 2017 In : Current Treatment Options in Oncology. 18, 2, 10

Research output: Research - peer-reviewReview article

Lymphoma
Therapeutics
Cost-Benefit Analysis
Recurrence
Patient Advocacy
2 Citations
Lymphoproliferative Disorders
T-Lymphocytes
Non-Hodgkin's Lymphoma
Therapeutics
Tumor Microenvironment